Alpha 1-antitrypsin deficiency: Difference between revisions
Jump to navigation
Jump to search
Mazia Fatima (talk | contribs) No edit summary |
Mazia Fatima (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Alpha-1 Antitrypsin deficiency}} | {{Alpha-1 Antitrypsin deficiency}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{Mazia}} | ||
'''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]] | '''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]] | ||
Revision as of 13:27, 12 December 2017
Template:Alpha-1 Antitrypsin deficiency Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
For patient information, click here Template:DiseaseDisorder infobox
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Alpha 1-antitrypsin deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies